Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless

Alkermes Inc (NASDAQ GS:ALKS)10:33 AM ET
most recent headlinesmore headlines:       
THURSDAY, FEBRUARY 04, 2010
4:00 PMAlkermes Reports Third Quarter Fiscal 2010 Financial Results - BusinessWire
8:30 AMAlkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders - BusinessWire
MONDAY, FEBRUARY 01, 2010
4:00 PMAlkermes' Corporate Presentation to be Webcast at the BIO CEO & Investor Conference - BusinessWire
THURSDAY, JANUARY 28, 2010
4:00 PMAlkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2010 - BusinessWire
TUESDAY, JANUARY 26, 2010
8:33 AMByetta LAR Will Become Decision Resources' New Clinical Gold Standard in 2013 for the Treatment of Type 2 Diabetes - PR Newswire
WEDNESDAY, JANUARY 06, 2010
4:00 PMAlkermes' Corporate Presentation to be Webcast at the 28th Annual JPMorgan Healthcare Conference - BusinessWire
TUESDAY, DECEMBER 15, 2009
8:15 AMExenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study - BusinessWire
8:00 AMExenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study - PR Newswire
TUESDAY, DECEMBER 08, 2009
4:00 PMAlkermes' Corporate Presentation to be Webcast at the Deutsche Bank Biotech Boston Confab - BusinessWire
THURSDAY, DECEMBER 03, 2009
12:00 PMAlkermes Licenses Technology Platform for Long-Acting Fusion Proteins from Acceleron Pharma - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.